Psyched Wellness Ltd
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Psyched Wellness Ltd. is a Canada-based health supplements company specializing in the research, development, and production of dietary supplements derived from the Amanita Muscaria mushroom. The company manufactures and distributes a product line that includes water-based extracts, teas, and capsules designed to promote stress relief, relaxation, and assist with restful sleeping. Its core products include the proprietary extract AME-1, Calm, and the recently launched Calmer, a twice-potent version of Calm with an enhanced flavor profile to reduce the mushroom taste while maintaining efficacy. Psyched Wellness markets its products primarily through online sales and select high-end retailers in the United States and Canada. The company was founded in 2020, evolving from its former identity as Duncan Park Holdings Corporation, and is headquartered in Toronto, Canada. Recent major developments include the launch of Calmer in November 2025 and the dietary supplement shot Santa introduced in October 2025 following pilot production runs. The company is actively pursuing a long-term manufacturing agreement to support growing demand and continues to expand its branding, sales, and marketing efforts. Psyched Wellness also experienced a supply chain disruption in mid-2024 at its sole U.S. manufacturing facility, which led to a temporary suspension of online sales to prioritize retail partners and subscription customers. Research and development efforts have intensified, with ongoing studies such as a Genotoxicity study for AME-1 initiated in early 2025. Strategic collaboration with consultants like Zerkalo is in progress to develop new dietary supplement products leveraging AME-1. The company targets the emerging functional food and dietary supplement markets in North America, focusing on health and wellness benefits related to psychoactive mushroom derivatives. Psyched Wellness's objective is to become a leading North American brand in this innovative sector, serving consumers seeking natural alternatives for mental and physical well-being. It is publicly traded under the ticker symbol PSYCF on the OTCQB Venture Market and CSE (Canada) and operates primarily in Canada and the United States. The company continues to emphasize product innovation, regulatory progress, and supply chain stabilization as key pillars of its growth strategy.
Psyched Wellness Provides Corporate Update
Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector
Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director
Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94
Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run
Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Announces Appointment of New Director and Resignation of a Director
Psyched Wellness Announces Supply Chain Disruption in the US
Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer
Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA
Psyched Wellness Announces Grant of Options
Psyched Wellness Closes Final US$2.5M Tranche of Its Non-Brokered Private Placement for a Total of US$7.5M with Gotham Green Partners and Provides Corporate Update
Psyched Wellness and Gotham Green Partners to Close Final Tranche of US$2.5M for a Total of US$7.5M Raised and Partner with Strategic Advisors to Build Consumer Packaged Goods Derived from AME-1
Psyched Wellness Provides Corporate Update
Psyched Wellness Provides Update on Non-Brokered Private Placement
Psyched Wellness's Calm, First Legal Amanita Muscaria Extract, Arrives at Pop-up Grocer in NYC
Psyched Wellness Is Pleased To Announce Sponsorship and Activation at The Wonderland Conference in Miami on Nov 9 - 11